» Articles » PMID: 38441732

Unveiling NUSAP1 As a Common Gene Signature Linking Chronic HBV Infection and HBV-related HCC

Overview
Journal Discov Oncol
Publisher Springer
Specialty Oncology
Date 2024 Mar 5
PMID 38441732
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis B virus (HBV) is a significant contributor to the development of hepatocellular carcinoma (HCC). Chronic HBV infection (CHB) facilitates disease progression through various mechanisms. However, the specific factor responsible for the progression of HBV infection to HCC remains unresolved. This study aims to identify the hub gene linking CHB and HBV-related HCC through bioinformatic analysis and experimental verification.

Methods: Differentially expressed genes (DEGs) were identified in datasets encompassing CHB and HBV-HCC patients from the GEO database. Enriched pathways were derived from GO and KEGG analysis. Hub genes were screened by protein-protein interaction (PPI) analysis and different modules in Cytoscape software. The significance of the selected hub gene in prognosis was further assessed in validated datasets. The effects of hub genes on cell growth and apoptosis were further determined in functional experiments.

Results: The study revealed upregulation of NUSAP1 in CHBs and HBV-HCCs. High expression of NUSAP1 served as an independent predictor for poor prognosis of liver cancers. Functional experiments demonstrated that NUSAP1 promotes cell growth, influences cell cycle process, and protects cells from apoptosis in HepG2.2.15 cells.

Conclusion: NUSAP1 serves as a poor prognostic indicator for liver cancers, and potentially plays a crucial role in HBV-HCC progression by promoting proliferation and inhibiting apoptosis.

Citing Articles

Comprehensive multi-omics analysis identifies NUSAP1 as a potential prognostic and immunotherapeutic marker for lung adenocarcinoma.

Ma J, Zhu W, Wang Y, Du H, Ma L, Liu L Int J Med Sci. 2025; 22(2):328-340.

PMID: 39781524 PMC: 11704694. DOI: 10.7150/ijms.102331.


Screening and molecular docking verification of feature genes related to phospholipid metabolism in hepatocarcinoma caused by hepatitis B.

Zhang J, Zhang F, Zhang L, Zhang M, Liu S, Ma Y Lipids Health Dis. 2024; 23(1):268.

PMID: 39182089 PMC: 11344459. DOI: 10.1186/s12944-024-02253-3.

References
1.
Chiu C, Li C, Verschueren E, Wen R, Zhang D, Gordon C . NUSAP1 Binds ILF2 to Modulate R-Loop Accumulation and DNA Damage in Prostate Cancer. Int J Mol Sci. 2023; 24(7). PMC: 10093842. DOI: 10.3390/ijms24076258. View

2.
Gordon C, Gulzar Z, Brooks J . NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells. Prostate. 2015; 75(5):517-26. DOI: 10.1002/pros.22938. View

3.
Xu Z, Wang Y, Xiong J, Cui F, Wang L, Peng H . NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling. J Cell Physiol. 2019; 235(4):3886-3893. DOI: 10.1002/jcp.29282. View

4.
Li J, Tang M, Wu J, Qu H, Tu M, Pan Z . NUSAP1, a novel stemness-related protein, promotes early recurrence of hepatocellular carcinoma. Cancer Sci. 2022; 113(12):4165-4180. PMC: 9746044. DOI: 10.1111/cas.15585. View

5.
Bardou P, Mariette J, Escudie F, Djemiel C, Klopp C . jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014; 15:293. PMC: 4261873. DOI: 10.1186/1471-2105-15-293. View